Components ID'd for ideal acne severity global grading tool

Components ID'd for ideal acne severity global grading tool
Using an established method for consensus building, experts have identified the essential clinical components and features for an acne severity global grading tool, according to research published in the August issue of the Journal of the American Academy of Dermatology.

(HealthDay) -- Using an established method for consensus building, experts have identified the essential clinical components and features for an acne severity global grading tool, according to research published in the August issue of the Journal of the American Academy of Dermatology.

Jerry Tan, M.D., from the University of Western Ontario in Windsor, Canada, and colleagues used an iterative method, the Delphi process, to determine the essential clinical components and features for an acne-grading scale for use in research and clinical practice. Ten experts participated in a Web-based Delphi survey, which included three iterative rounds of questions.

The researchers found that, in round 1, primary acne , number of lesions, extent, regional involvement, secondary lesions, and patient experiences were identified as clinical components; features included clinimetric properties, ease of use, categorization of severity based on photographs or text, and acceptance by all stakeholders. In round 2, a consensus was established for inclusion in the scale for primary lesions, number, site, and extent, and for clinimetric properties and ease of use. For categorization and acceptance, consensus for inclusion was further established in round 3. No consensus was achieved for secondary lesions, and patient experiences were excluded.

"Using an established method for achieving consensus, experts in acne vulgaris concluded that an ideal acne global grading scale would comprise the essential clinical components of primary lesions, their quantity, extent, and facial and extrafacial sites of involvement; with features of clinimetric properties, categorization, efficiency, and acceptance," the authors write.

Several authors disclosed to , many of which manufacture dermatological products.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Dual mode laser therapy effectively treats acne vulgaris

Mar 27, 2012

(HealthDay) -- A series of Nd:YAG laser treatments effectively and rapidly reduces both inflammatory and noninflammatory acne vulgaris lesions, according to a study published in the April issue of the Journal of ...

How the drug isotretinoin zaps acne

Mar 03, 2008

The most potent drug available for the treatment of acne is 13-cis retinoic acid (13-cis RA; also known as isotretinoin); however, little is known about the mechanism by which it acts.

Recommended for you

Two expats die of MERS in Saudi commercial hub

14 hours ago

Two foreigners died of MERS in the Saudi city of Jeddah, the health ministry said Saturday, as fears rise over the spreading respiratory virus in the kingdom's commercial hub.

UAE reports 12 new cases of MERS

14 hours ago

Health authorities in the United Arab Emirates have announced 12 new cases of infection by the MERS coronavirus, but insisted the patients would be cured within two weeks.

Filipino tests negative for Middle East virus

Apr 19, 2014

A Filipino nurse who tested positive for the Middle East virus has been found free of infection in a subsequent examination after he returned home, Philippine health officials said Saturday.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

alfie_null
3 / 5 (1) Jul 22, 2012
Can't really fault pharma for chasing the best potential profits. Still a sad situation, considering what could be done with those R&D resources.